A Retrospective Study Analysing Clinical Predictors of Treatment Failure to Anti-IL5 Therapy in Severe Eosinophilic Asthma
Latest Information Update: 05 Jul 2020
At a glance
- Drugs Benralizumab (Primary) ; Mepolizumab (Primary) ; Reslizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
Most Recent Events
- 04 Jul 2020 New trial record
- 20 May 2020 Results presented at the 116th International Conference of the American Thoracic Society